IN

Infinium Pharmachem LtdNSE INFINIUM

Последний отчетный период 30 сент., 2023

Обновлено 19 сент., 2024

Последняя цена

Капитализация млрд. $

0.012

Micro

Биржа

XNSE - National Stock Exchange Of India

Анализ акций INFINIUM.NS

IN

Нет оценки

Количественный анализ Eyestock не покрывает акции Infinium Pharmachem Ltd.

Капитализация млрд. $

0.012

Дивидендная доходность

Оборот

13.916 млрд

Сайт компании

https://infiniumpharmachem.com/

Infinium Pharmachem Ltd. manufactures and supplies iodine derivatives. The company is headquartered in Vallabh Vidyanagar, Gujarat. The company went IPO on 2023-04-17. The firm is involved in the development, manufacture, and export of a spectrum of the Iodine Derivatives that are used in pharmaceutical, chemical, biotech and allied industries across the globe. The firm's portfolio includes approximately 200+ Iodine Derivatives and seven+ APIs. The company manufactures and supplies a range of Iodine based APIs, but on Order to Made basis only. The company offers bulk actives, intermediates and services for custom synthesis. The company also provides contract Research and manufacturing Services to the pharmaceutical and biotech companies for their diverse requirements of Iodine based APIs and intermediates to reduce their research time and project cost. The company manufactures iodine derivatives for the various industries, including pharmaceutical, chemical, nutraceutical, cosmetics, sanitation, agrochemical, electronics, Nylon production and other industries for their range of industrial applications.

Смотреть Секцию: Рейтинг